5
Orphan Designations
0
FDA Approvals
12
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Finnish type amyloidosis | Combretastatin A4 Phosphate | Orphan Designation | - |
| acute myeloid leukemia | combretastatin A 1 diphosphate | Orphan Designation | - |
| anaplastic astrocytoma | Combretastatin A4 Phosphate | Orphan Designation | - |
| anaplastic ependymoma | Combretastatin A4 Phosphate | Orphan Designation | - |
| central nervous system anaplastic large cell lymphoma | Combretastatin A4 Phosphate | Orphan Designation | - |
| cutaneous neuroendocrine carcinoma | fosbretabulin tromethamine | Orphan Designation | - |
| glioma | fosbretabulin tromethamine | Orphan Designation | - |
| ovarian cancer | Combretastatin A4 phosphate | Orphan Designation | - |
| pancreatic neuroendocrine neoplasm | fosbretabulin tromethamine | Orphan Designation | - |
| pancreatic neuroendocrine tumor | fosbretabulin tromethamine | Orphan Designation | - |
| thymoma | Combretastatin A4 Phosphate | Orphan Designation | - |
| thyroid gland undifferentiated (anaplastic) carcinoma | Combretastatin A4 Phosphate | Orphan Designation | - |